• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Adamantinoma

Adamantinoma - 55 Studies Found

Recruiting : An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
:
  • Abnormalities
  • Craniopharyngioma
  • Drug: Exenatide Weekly injecti

Completed : Stereotactic Radiosurgery in Treating Patients With Brain Tumors
:
  • Adult Central Nervous System Germ Cell Tumor
  • Adult Malignant Meningioma
  • Neuroblastoma
  • Medulloblastoma
  • Glioma
  • Brain Tumors and/or Solid Tumors Including
  • Brain Stem Glioma
  • Central Nervous System Tumor, Pediatric
  • Fatigue
  • Specific D
    : 2011-05-04
    :
    • Drug: methylphenidate hydrochloride

Completed : SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors
: Brain and Central Nervous System Tumors
: 2001-05-06
: Drug: lonafarnib Other Name: SCH 66336
Terminated : SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
: Brain and Central Nervous System Tumors
: 2000-09-11
: Drug: semaxanib Other Name: SU5416
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.